MedTrace Logo

Olpasiran Expanded Access Program

NCT07079267 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2025-07-23

No results posted yet for this study

Summary

Expanded access requests for Olpasiran may be considered for adult participants with elevated Lp(a) and atherosclerotic cardiovascular disease (ASCVD). To request access, use Responsible Party contact information provided in this record.

Interventions

DRUG

Olpasiran

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07079267 on ClinicalTrials.gov